We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

86 hedge funds and large institutions have $98.5M invested in Cascadian Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more call options, than puts

Call options by funds: $463K | Put options by funds: $201K

106% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 17

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more capital invested

Capital invested by funds: $98.3M → $98.5M (+$156K)

0% more funds holding

Funds holding: 86 → 86 (0)

Holders
86
Holders Change
–
Holders Change %
0%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
35
Reduced
17
Closed
13
Calls
$463K
Puts
$201K
Net Calls
+$262K
Net Calls Change
-$552K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$7.05M
2
BC
Broadfin Capital
New York
+$904K
3
JP Morgan Chase
JP Morgan Chase
New York
+$696K
4
OAM
Oxford Asset Management
United Kingdom
+$575K
5
BFA
BlackRock Fund Advisors
California
+$566K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$7.5M
2
DM
Deerfield Management
New York
-$3.35M
3
QF
QVT Financial
New York
-$3.01M
4
ERSOT
Employees Retirement System of Texas
Texas
-$1.71M
5
GTC
Ghost Tree Capital
New York
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
26
Perceptive Advisors
New York
$618K – – –
OAM
27
Oxford Asset Management
United Kingdom
$605K +$575K +52,986 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$598K +$11K +1,018 +2%
TCIM
29
TIAA CREF Investment Management
New York
$526K +$36.5K +3,366 +8%
WMSA
30
Weiss Multi-Strategy Advisers
New York
$437K +$54.3K +5,000 +15%
BIM
31
BlackRock Investment Management
Delaware
$430K +$6.22K +573 +2%
Deutsche Bank
32
Deutsche Bank
Germany
$328K +$312K +28,733 +25,204%
Nomura Holdings
33
Nomura Holdings
Japan
$303K -$57.1K -5,258 -16%
TI
34
Telemetry Investments
New York
$295K +$281K +25,917 New
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$290K +$162K +14,894 +141%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$284K +$1.15K +106 +0.4%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$271K – – –
Charles Schwab
38
Charles Schwab
California
$247K – – –
CI
39
Cowen Inc
New York
$190K -$1.8K -166 -1%
TA
40
Teachers Advisors
New York
$187K – – –
TC
41
TFS Capital
Pennsylvania
$161K -$407K -37,539 -73%
Stifel Financial
42
Stifel Financial
Missouri
$159K +$152K +13,961 New
SG Americas Securities
43
SG Americas Securities
New York
$146K +$93.5K +8,616 +205%
CS
44
Credit Suisse
Switzerland
$129K +$91.4K +8,419 +285%
VOYA Investment Management
45
VOYA Investment Management
Georgia
$116K – – –
NFA
46
Nationwide Fund Advisors
Ohio
$115K +$9.39K +865 +9%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$109K +$5.07K +467 +5%
Connor, Clark & Lunn Investment Management (CC&L)
48
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$109K +$54.5K +5,017 +111%
Morgan Stanley
49
Morgan Stanley
New York
$107K -$46.8K -4,314 -32%
LTFS
50
Ladenburg Thalmann Financial Services
Florida
$107K +$15.5K +1,432 +18%
1
2
3 4

CASC Hedge Fund Activity: Q4 2014 in Review

86 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q4 2014, worth a combined $98.5M — up 0.16% from $98.3M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CASC positions and 13 closed out — a net gain of 1 holder — while 35 added to existing stakes and 17 trimmed.

The largest buyer was BVF Inc, adding an estimated $7.05M. The largest seller was Great Point Partners, exiting entirely with an estimated $7.5M sold.

  • 86 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $98.5M of Cascadian Therapeutics, Inc. stock for Q4 2014, up 0.16% quarter-over-quarter.
  • 14 funds opened new Cascadian Therapeutics, Inc. positions in Q4 2014 and 13 closed out, a net change of +1 holder.
  • The largest Cascadian Therapeutics, Inc. buyer in Q4 2014 was BVF Inc, an estimated $7.05M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q4 2014 was Great Point Partners, an estimated $7.5M sold.

Based on aggregated 13F filings for Q4 2014.